Charles Schwab Investment Management Inc Savara Inc Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Savara Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 995,511 shares of SVRA stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

995,511

Previous 954,830 4.26%

Holding current value

$4.22 Million

Previous $2.64 Million 14.18%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.99 - $3.4 $80,955 - $138,315	40,681 Added 4.26%	995,511 $2.27 Million
Q1 2025 Sep 15, 2025	SELL	$2.32 - $3.14 $94,379 - $127,738	-40,681 Reduced 4.09%	954,830 $2.64 Million
Q1 2025 May 09, 2025	SELL	$2.32 - $3.14 $20,859 - $28,231	-8,991 Reduced 0.93%	954,830 $2.64 Million
Q4 2024 Feb 06, 2025	BUY	$2.94 - $4.07 $153,479 - $212,470	52,204 Added 5.73%	963,821 $2.96 Million
Q3 2024 Nov 12, 2024	BUY	$3.96 - $5.07 $2.54 Million - $3.26 Million	642,259 Added 238.44%	911,617 $3.87 Million
Q2 2024 Aug 12, 2024	BUY	$3.66 - $5.34 $98,025 - $143,021	26,783 Added 11.04%	269,358 $1.09 Million
Q1 2024 May 08, 2024	SELL	$4.19 - $5.59 $25,085 - $33,467	-5,987 Reduced 2.41%	242,575 $1.21 Million
Q3 2023 Nov 08, 2023	BUY	$2.97 - $3.88 $101,609 - $132,742	34,212 Added 15.96%	248,562 $939,000
Q2 2023 Aug 09, 2023	BUY	$1.69 - $3.24 $315,710 - $605,267	186,811 Added 678.35%	214,350 $683,000
Q1 2023 May 11, 2023	SELL	$1.6 - $2.82 $24,548 - $43,267	-15,343 Reduced 35.78%	27,539 $53,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.29 $86,331 - $130,926	-57,173 Reduced 57.14%	42,882 $73,000
Q1 2021 May 17, 2021	SELL	$1.17 - $2.33 $10,179 - $20,271	-8,700 Reduced 8.0%	100,055 $209,000
Q2 2020 Aug 14, 2020	BUY	$1.8 - $3.05 $52,772 - $89,419	29,318 Added 36.91%	108,755 $271,000
Q1 2020 May 15, 2020	BUY	$1.91 - $4.08 $2,708 - $5,785	1,418 Added 1.82%	79,437 $169,000
Q2 2019 Aug 09, 2019	BUY	$2.37 - $11.7 $44,337 - $218,883	18,708 Added 31.54%	78,019 $185,000
Q1 2019 May 14, 2019	SELL	$6.71 - $8.6 $13,332 - $17,088	-1,987 Reduced 3.24%	59,311 $438,000
Q3 2018 Nov 13, 2018	BUY	$10.49 - $12.87 $80,143 - $98,326	7,640 Added 14.24%	61,298 $685,000
Q2 2018 Aug 08, 2018	BUY	$8.55 - $13.76 $458,775 - $738,334	53,658 New	53,658 $608,000

Others Institutions Holding SVRA

# of Institutions

127

Shares Held

167M

Call Options Held

38.7K

Put Options Held

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $484M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Savara Inc Transaction History